Oct 28 (Reuters) - Chinese AI developers DeepSeek and Moonshot AI relied heavily on outputs from OpenAI's powerful GPT-6 Astra model to train their latest models, The Information reported on Wednesday ...

Singapore's Keppel reported an over 20% growth in its nine-month net profit on Thursday, excluding its non-core portfolio for divestment and discontinued operations, helped by strong performance in ...

For 2027, the ECB confirmed the overall Pillar 2 Requirement at 2.25%, unchanged from 2026. Starting January 1, 2027, the minimum Common Equity Tier 1 ratio requirement to be met on a consolidated ...

Month figures PALFINGER AG: PALFINGER sharpens portfolio and risk profile, strengthening focus, profitability and resilience in the third quarter 2026 28.10.2026 / 07:02 CET/CEST The issuer is solely ...

ASM International NV provided earnings guidance fourth quarter of 2026, Full year 2026 and year 2027. For the quarter, the company's revenue is projected to increase to ?1,230 million +/-5% in Fourth ...

Marvell shares were down 9.3% to $228.31 in after-hours trading on Wednesday. The stock closed up 3.3% to $251.65, and had nearly tripled in value year to date through the close. Shares of Lumentum, ...

Mr. Von Bose joined LOM in early 1973 in Montreal where he had been a partner with an old Montreal firm in charge of institutional sales. From 1975 -1983 he worked out of the company's Geneva office, ...

William H. L. Burnside currently serves as Independent Director at AbbVie, Inc. since 2013. He is also a Director at Executive Service Corps of Southern California and Audubon California, Inc.

Dhaka Bank Plc, founded in 1995, where the title held is Chairman. Mr. Sarker is the founder of Purbani Group, founded in 1973, holding the titles of Chairman, Chief Executive Officer & MD. Mr. Sarker ...

US Total Weekly EIA Crude Oil Stocks Fall by 2.0 Million Barrels After Prior 3.4 Million Decrease MT 10:02am Bank of Canada head sees less room for monetary accommodation RE 09:34am World Bank sees ...

Information reconciling certain forward-looking GAAP measures to non-GAAP measures related to FY 2026 guidance, including organic net sales growth, adjusted operating margin and adjusted free cash ...

Biotech company Genmab reports positive results from the Phase 3 LiGeR-HN1 study, in which petosemtamab in combination with pembrolizumab reduced the risk of death by 50 percent compared with ...